Hui Zhang

机构：Shanghai Center for Brain Science and Brain-Inspired Technology · ORCID：0009-0009-3800-975X

发表论文 69 篇 · 总被引 997 次 · h-index 16

代表论文

• Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma (2022 · Journal of Biomedical Science · 被引 19)
• A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer’s Disease (2021 · BioMed Research International · 被引 16)
• Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis (2025 · Journal of Biomedical Science · 被引 8)
• Inhibiting Liver‐Derived C3 Protein Rescues Anesthesia/Surgery‐Induced Cognitive Impairment, Synaptic Disorders, and Microglial Phagocytosis (2025 · Advanced Science · 被引 7)
• Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence (2023 · Chinese Journal of Cancer Research · 被引 7)
• Circulating microbiome DNA features and its effect on predicting clinicopathological characteristics of patients with colorectal cancer (2025 · Journal of Translational Medicine · 被引 6)